208 related articles for article (PubMed ID: 32274874)
1. Protocol for the development of a core domain set for hand eczema trials.
Rönsch H; Apfelbacher C; Brans R; Ofenloch R; Schuttelaar MLA; Weisshaar E; Bauer A
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2871-2876. PubMed ID: 32274874
[TBL] [Abstract][Full Text] [Related]
2. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
[TBL] [Abstract][Full Text] [Related]
3. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
[TBL] [Abstract][Full Text] [Related]
4. [Core outcome measurements in hand eczema trials : The HECOS initiative].
Rönsch H; Bauer A; Apfelbacher C
Hautarzt; 2019 Oct; 70(10):773-777. PubMed ID: 31359075
[TBL] [Abstract][Full Text] [Related]
5. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
[TBL] [Abstract][Full Text] [Related]
6. Outcomes for Pressure Ulcer Trials (OUTPUTs): protocol for the development of a core domain set for trials evaluating the clinical efficacy or effectiveness of pressure ulcer prevention interventions.
Lechner A; Kottner J; Coleman S; Muir D; Bagley H; Beeckman D; Chaboyer W; Cuddigan J; Moore Z; Rutherford C; Schmitt J; Nixon J; Balzer K
Trials; 2019 Jul; 20(1):449. PubMed ID: 31331366
[TBL] [Abstract][Full Text] [Related]
7. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R
Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910
[TBL] [Abstract][Full Text] [Related]
8. COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults.
Duane S; Vellinga A; Murphy AW; Cormican M; Smyth A; Healy P; Moore M; Little P; Devane D
Trials; 2019 Feb; 20(1):106. PubMed ID: 30732617
[TBL] [Abstract][Full Text] [Related]
9. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
[TBL] [Abstract][Full Text] [Related]
10. Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey.
Rönsch H; Schiffers F; Ofenloch R; Weisshaar E; Buse AS; Hansen A; John SM; Giménez Arnau AM; Pesqué D; Agner T; Nørreslet LB; Loman L; Romeijn GLE; Schuttelaar MLA; Košćec Bjelajac A; Macan J; Bauer A; Apfelbacher CJ
J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):1199-1206. PubMed ID: 36695080
[TBL] [Abstract][Full Text] [Related]
11. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
[TBL] [Abstract][Full Text] [Related]
12. Development of a Core Outcome Set for Studies on Cardiac Disease in Pregnancy (COSCarP): a study protocol.
D'Souza R; Hall C; Sermer M; Siu S; Silversides C
Trials; 2020 Mar; 21(1):300. PubMed ID: 32228655
[TBL] [Abstract][Full Text] [Related]
13. Which outcomes have been measured in hand eczema trials? A systematic review.
Rönsch H; Apfelbacher C; Brans R; Matterne U; Molin S; Ofenloch R; Oosterhaven JAF; Schuttelaar MLA; Weisshaar E; Yew YW; Bauer A
Contact Dermatitis; 2019 Apr; 80(4):201-207. PubMed ID: 30632613
[TBL] [Abstract][Full Text] [Related]
14. Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET).
Mitchell JW; Noble A; Baker G; Batchelor R; Brigo F; Christensen J; French J; Gil-Nagel A; Guekht A; Jette N; Kälviäinen R; Leach JP; Maguire M; O'Brien T; Rosenow F; Ryvlin P; Tittensor P; Tripathi M; Trinka E; Wiebe S; Williamson PR; Marson T
Trials; 2022 Nov; 23(1):943. PubMed ID: 36397081
[TBL] [Abstract][Full Text] [Related]
15. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
Harman NL; Wilding J; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
Trials; 2018 Aug; 19(1):427. PubMed ID: 30086771
[TBL] [Abstract][Full Text] [Related]
16. Standardising the reporting of outcomes in gastric cancer surgery trials: protocol for the development of a core outcome set and accompanying outcome measurement instrument set (the GASTROS study).
Alkhaffaf B; Glenny AM; Blazeby JM; Williamson P; Bruce IA
Trials; 2017 Aug; 18(1):370. PubMed ID: 28793921
[TBL] [Abstract][Full Text] [Related]
17. Development of a core outcome set and outcome measurement set for physiotherapy trials in adults with Bronchiectasis (COS-PHyBE study): A protocol.
Hamzeh H; Spencer S; Kelly C
PLoS One; 2022; 17(2):e0263695. PubMed ID: 35134099
[TBL] [Abstract][Full Text] [Related]
18. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
Trials; 2020 May; 21(1):437. PubMed ID: 32460828
[TBL] [Abstract][Full Text] [Related]
19. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
Trials; 2014 Dec; 15():511. PubMed ID: 25540987
[TBL] [Abstract][Full Text] [Related]
20. Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.
van Geel N; Hamzavi IH; Pandya AG; Wolkerstorfer A; Seneschal J; Garg A; Spuls P; Terwee CB; Mallett S; Speeckaert R; Meurant JM; Eleftheriadou V; Ezzedine K
Trials; 2022 Jul; 23(1):591. PubMed ID: 35871019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
